| Formulary Chapter 11: Eye - Full Chapter
|
 |
- Aciclovir interferes specifically with viral DNA replication. Topical aciclovir has been found to be effective in localised herpes simplex infections. Systemic treatment should be used for ophthalmic herpes zoster (see Antimicrobial website ).
- As frequent slit-lamp examinations are necessary to monitor progress, patients with herpes simplex keratitis should be managed by an ophthalmologist.
- Topical antiviral agents can be toxic to the corneal epithelium on prolonged use.
|
|
Key |
|
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.
All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry |
|
Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum). |
|
Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.
|
|
Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required. |
|
Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.
|
|
Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.
|
|
|
